BESIFLOXACIN

BESIFLOXACIN was reported 969 times

BESIFLOXACIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DIFFUSE LAMELLAR KERATITIS 10 0.2381
1 CORNEAL FLAP COMPLICATION 3 0.1667
2 LACRIMAL CYST 1 0.1250
3 CORNEAL STRIAE 8 0.1127
4 ANTIBIOTIC RESISTANT STAPHYLOCOCCUS TEST 1 0.0588
5 CORNEAL INFILTRATES 18 0.0573
6 DRUG DISPENSING ISSUE 1 0.0526
7 ANTERIOR CHAMBER FIBRIN 6 0.0465
8 CORNEAL THICKENING 3 0.0441
9 INSTILLATION SITE HYPERSENSITIVITY 1 0.0435
10 CHEMICAL EYE INJURY 4 0.0408
11 CORNEAL IRRITATION 3 0.0375
12 RETINAL LASER COAGULATION 1 0.0370
13 STAPHYLOMA 1 0.0323
14 PUPILLARY BLOCK 1 0.0312
15 FLOPPY EYELID SYNDROME 1 0.0286
16 FIBRIN 1 0.0233
17 DEVICE MATERIAL OPACIFICATION 1 0.0222
18 ATRIAL APPENDAGE CLOSURE 1 0.0200
19 BLEPHAROCHALASIS 1 0.0200
20 STAPHYLOCOCCUS TEST 1 0.0189
21 THROMBOSED VARICOSE VEIN 1 0.0189
22 ABSCESS OF EYELID 1 0.0179
23 CORNEAL PIGMENTATION 1 0.0175
24 CORNEAL EPITHELIUM DEFECT 10 0.0172
25 INCISION SITE INFLAMMATION 2 0.0169
26 HYPOPYON 13 0.0157
27 TOXIC ANTERIOR SEGMENT SYNDROME 17 0.0156
28 CORNEAL ENDOTHELIAL CELL LOSS 1 0.0147
29 PUNCTATE KERATITIS 13 0.0142
30 CORNEAL OPACITY 19 0.0139
31 RETINAL FIBROSIS 1 0.0139
32 INSTILLATION SITE FOREIGN BODY SENSATION 2 0.0138
33 CORNEAL OEDEMA 30 0.0134
34 EYE INFECTION INTRAOCULAR 1 0.0128
35 POSTERIOR CAPSULE RUPTURE 1 0.0127
36 PUPILLARY DEFORMITY 1 0.0125
37 KERATITIS BACTERIAL 2 0.0123
38 MACULAR CYST 1 0.0119
39 ASTHMA LATE ONSET 1 0.0116
40 CORNEAL DEPOSITS 8 0.0108
41 CORNEAL TRANSPLANT 8 0.0102
42 ANTERIOR CHAMBER CELL 7 0.0098
43 SKIN GRAFT FAILURE 1 0.0094
44 EYE INFECTION VIRAL 3 0.0093
45 ANTERIOR CHAMBER FLARE 2 0.0086
46 CORNEAL ABRASION 11 0.0080
47 CORNEAL DEFECT 1 0.0076
48 DEPOSIT EYE 2 0.0075
49 CORNEAL EROSION 4 0.0074
50 VITREOUS HAZE 1 0.0065
51 INFECTIVE GLOSSITIS 1 0.0064
52 ULCERATIVE KERATITIS 17 0.0062
53 CORNEAL EPITHELIAL MICROCYSTS 1 0.0060
54 POSTERIOR CAPSULE OPACIFICATION 2 0.0058
55 INSTILLATION SITE SWELLING 1 0.0057
56 OPHTHALMOLOGICAL EXAMINATION ABNORMAL 1 0.0056
57 CORNEAL DISORDER 12 0.0055
58 VISUAL ACUITY TESTS ABNORMAL 3 0.0054
59 SCROTAL ABSCESS 2 0.0053
60 EYE ULCER 3 0.0052
61 FOREIGN BODY SENSATION IN EYES 33 0.0052
62 OCULAR PROCEDURAL COMPLICATION 1 0.0052
63 RETINOPATHY PROLIFERATIVE 1 0.0051
64 RETINAL ANEURYSM 1 0.0050
65 VITREAL CELLS 1 0.0050
66 KERATITIS FUNGAL 1 0.0048
67 CORNEAL GRAFT REJECTION 1 0.0048
68 RETINAL PIGMENT EPITHELIOPATHY 2 0.0046
69 CORNEAL INFECTION 1 0.0046
70 SUPERFICIAL INJURY OF EYE 5 0.0046
71 OCULAR TOXICITY 5 0.0045
72 CATARACT NUCLEAR 3 0.0045
73 OPTIC DISC HAEMORRHAGE 1 0.0044
74 SPLINTER 1 0.0043
75 ANTERIOR CHAMBER DISORDER 1 0.0043
76 RETINAL SCAR 2 0.0043
77 EUSTACHIAN TUBE DISORDER 1 0.0042
78 PILONIDAL DISEASE 1 0.0042
79 ENDOPHTHALMITIS 24 0.0040
80 GLAUCOMA SURGERY 1 0.0039
81 PRODUCT DROPPER ISSUE 3 0.0038
82 INSTILLATION SITE DISCHARGE 1 0.0038
83 NEOVASCULARISATION 1 0.0038
84 CYSTOID MACULAR OEDEMA 7 0.0037
85 EYE INFECTION BACTERIAL 2 0.0036
86 LENS DISORDER 1 0.0035
87 REFRACTION DISORDER 1 0.0034
88 ANTERIOR CHAMBER INFLAMMATION 2 0.0034
89 MEDICATION RESIDUE PRESENT 16 0.0033
90 RETINOPATHY HYPERTENSIVE 1 0.0033
91 IMPAIRED FASTING GLUCOSE 1 0.0033
92 PUPILLARY LIGHT REFLEX TESTS ABNORMAL 1 0.0032
93 TRICHIASIS 1 0.0031
94 MACULAR FIBROSIS 2 0.0029
95 PSEUDOSTROKE 1 0.0029
96 MULTIPLE DRUG THERAPY 2 0.0027
97 ACCELERATED HYPERTENSION 1 0.0026
98 LUMBAR PUNCTURE 1 0.0026
99 KERATITIS 8 0.0026
100 EYE INFECTION FUNGAL 1 0.0026
101 PRODUCT DEPOSIT 4 0.0026
102 DISEASE RISK FACTOR 1 0.0025
103 LAGOPHTHALMOS 1 0.0024
104 CORNEAL DYSTROPHY 1 0.0024
105 HYPERPARATHYROIDISM SECONDARY 6 0.0024
106 HYPOTONY OF EYE 1 0.0024
107 NON-INFECTIOUS ENDOPHTHALMITIS 2 0.0024
108 LENTICULAR OPACITIES 1 0.0023
109 FACIAL NERVE DISORDER 1 0.0023
110 MEIBOMIAN GLAND DYSFUNCTION 1 0.0022
111 PRODUCT PHYSICAL CONSISTENCY ISSUE 12 0.0022
112 INFUSION SITE HAEMATOMA 1 0.0021
113 EYE INFLAMMATION 20 0.0021
114 EYELID MARGIN CRUSTING 6 0.0021
115 ECZEMA NUMMULAR 1 0.0020
116 EAR INJURY 1 0.0020
117 INSTILLATION SITE PAIN 5 0.0020
118 CORNEAL SCAR 1 0.0020
119 IRITIS 6 0.0020
120 CATARACT OPERATION COMPLICATION 1 0.0020
121 GLARE 1 0.0019
122 NEPHROGENIC ANAEMIA 9 0.0019
123 INJURY CORNEAL 1 0.0019
124 HYPHAEMA 1 0.0019
125 PHOTOPHOBIA 36 0.0019
126 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
127 IRIS DISORDER 1 0.0019
128 EYE PAIN 104 0.0018
129 RENAL ISCHAEMIA 1 0.0018
130 EYE DISCHARGE 19 0.0018
131 METASTASES TO KIDNEY 1 0.0018
132 PRODUCT CLOSURE ISSUE 1 0.0018
133 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 2 0.0018
134 OCULAR DISCOMFORT 20 0.0018
135 EJECTION FRACTION 1 0.0017
136 RETINAL VASCULAR DISORDER 1 0.0017
137 EYE BURNS 1 0.0017
138 INSTILLATION SITE IRRITATION 2 0.0017
139 CONJUNCTIVAL HYPERAEMIA 6 0.0017
140 RETINAL ISCHAEMIA 1 0.0016
141 EYE OEDEMA 4 0.0016
142 CORNEAL PERFORATION 1 0.0016
143 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
144 EPISCLERITIS 1 0.0014
145 ABNORMAL SENSATION IN EYE 6 0.0014
146 EYE IRRITATION 79 0.0014
147 SLEEP PARALYSIS 2 0.0014
148 KERATOPATHY 2 0.0013
149 OCULAR HYPERAEMIA 60 0.0013
150 REACTION TO PRESERVATIVES 1 0.0012
151 EYELID IRRITATION 3 0.0012
152 ENDOCRINE OPHTHALMOPATHY 1 0.0012
153 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 1 0.0011
154 OROPHARYNGEAL CANDIDIASIS 1 0.0011
155 INTRAOCULAR PRESSURE INCREASED 14 0.0011
156 CERUMEN IMPACTION 1 0.0011
157 DISTURBANCE IN SEXUAL AROUSAL 1 0.0011
158 VITREOUS HAEMORRHAGE 3 0.0011
159 RETINAL EXUDATES 1 0.0011
160 EYE INFECTION 12 0.0011
161 INTRACRANIAL MASS 1 0.0011
162 CONJUNCTIVAL HAEMORRHAGE 4 0.0010
163 FOREIGN BODY IN EYE 1 0.0010
164 COLON NEOPLASM 1 0.0010
165 IMPAIRED HEALING 34 0.0010
166 HYPERVIGILANCE 1 0.0010
167 BLEPHARITIS 4 0.0010
168 CONJUNCTIVAL OEDEMA 1 0.0010
169 EYE CONTUSION 2 0.0009
170 BONE DEMINERALISATION 1 0.0009
171 DRY AGE-RELATED MACULAR DEGENERATION 1 0.0009
172 HALO VISION 1 0.0009
173 EYE OPERATION 4 0.0009
174 SINUS PAIN 2 0.0009
175 LABILE BLOOD PRESSURE 1 0.0008
176 LIQUID PRODUCT PHYSICAL ISSUE 6 0.0008
177 SWELLING OF EYELID 5 0.0008
178 NOCTURNAL DYSPNOEA 1 0.0008
179 ABDOMINAL INFECTION 2 0.0008
180 INFUSION SITE IRRITATION 1 0.0008
181 RETINAL DISORDER 2 0.0008
182 ENCEPHALITIS AUTOIMMUNE 1 0.0008
183 HERPES OPHTHALMIC 1 0.0008
184 MACULAR HOLE 1 0.0007
185 SIALOADENITIS 1 0.0007
186 ABSCESS ORAL 1 0.0007
187 INFUSION SITE RASH 1 0.0007
188 IMMUNOGLOBULINS DECREASED 1 0.0007
189 EYE SWELLING 27 0.0007
190 DISCHARGE 1 0.0007
191 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
192 MACULAR OEDEMA 4 0.0007
193 VITREOUS FLOATERS 7 0.0007
194 SEBORRHOEIC KERATOSIS 1 0.0007
195 DARK CIRCLES UNDER EYES 1 0.0007
196 CATARACT OPERATION 4 0.0007
197 REBOUND ACID HYPERSECRETION 2 0.0007
198 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
199 EYE ALLERGY 1 0.0006
200 NEOPLASM SKIN 1 0.0006
201 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1 0.0006
202 VISION BLURRED 82 0.0006
203 EROSIVE OESOPHAGITIS 1 0.0006
204 PRODUCT CONTAINER ISSUE 5 0.0006
205 CERVICAL SPINAL STENOSIS 1 0.0006
206 ACUTE SINUSITIS 1 0.0006
207 SENSITIVITY OF TEETH 1 0.0006
208 TREATMENT DELAYED 1 0.0006
209 SPONDYLOLISTHESIS 1 0.0006
210 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
211 VISUAL ACUITY REDUCED 19 0.0006
212 FANCONI SYNDROME ACQUIRED 1 0.0006
213 RETINAL HAEMORRHAGE 4 0.0006
214 PRODUCT DELIVERY MECHANISM ISSUE 3 0.0006
215 ERYTHEMA OF EYELID 3 0.0006
216 CHRONIC KIDNEY DISEASE 42 0.0006
217 VITRITIS 1 0.0005
218 PLASMACYTOMA 1 0.0005
219 EYE PRURITUS 18 0.0005
220 CARDIAC DISORDER 50 0.0005
221 LACRIMATION INCREASED 16 0.0005
222 RETINAL OEDEMA 1 0.0005
223 EYELID OEDEMA 6 0.0005
224 OCULAR HYPERTENSION 1 0.0005
225 NASAL SEPTUM DEVIATION 1 0.0005
226 EYELID PAIN 1 0.0005
227 CATARACT 29 0.0005
228 CHOLANGITIS SCLEROSING 1 0.0005
229 PHOTOPSIA 3 0.0005
230 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
231 MYDRIASIS 6 0.0005
232 CATHETER SITE ERYTHEMA 1 0.0005
233 OCULOGYRIC CRISIS 1 0.0005
234 INFUSION SITE BRUISING 1 0.0005
235 HORDEOLUM 2 0.0005
236 VITREOUS DETACHMENT 1 0.0005
237 PRODUCT LOT NUMBER ISSUE 1 0.0005
238 DRY EYE 22 0.0004
239 ORAL PRURITUS 1 0.0004
240 EYELID DISORDER 1 0.0004
241 NECK SURGERY 1 0.0004
242 PUSTULE 1 0.0004
243 MYOPIA 1 0.0004
244 LONG QT SYNDROME 1 0.0004
245 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 1 0.0004
246 ANGLE CLOSURE GLAUCOMA 1 0.0004
247 MEDICATION RESIDUE 1 0.0004
248 ACTINIC KERATOSIS 1 0.0004
249 END STAGE RENAL DISEASE 7 0.0004
250 PROTEIN TOTAL INCREASED 1 0.0004
251 HYPERSENSITIVITY 68 0.0004
252 RENAL CANCER STAGE IV 1 0.0004
253 RHINALGIA 1 0.0004
254 PERIORBITAL SWELLING 2 0.0004
255 RETINAL VEIN OCCLUSION 1 0.0003
256 NECK INJURY 1 0.0003
257 STRABISMUS 1 0.0003
258 ATYPICAL PNEUMONIA 1 0.0003
259 RETINAL DETACHMENT 3 0.0003
260 BACTERIAL SEPSIS 1 0.0003
261 DEAFNESS NEUROSENSORY 1 0.0003
262 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0003
263 EYE HAEMORRHAGE 4 0.0003
264 POTENTIATING DRUG INTERACTION 1 0.0003
265 DIABETIC RETINOPATHY 1 0.0003
266 DRUG TOXICITY 4 0.0003
267 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
268 EAR DISCOMFORT 3 0.0003
269 EYE MOVEMENT DISORDER 2 0.0003
270 TEMPERATURE INTOLERANCE 3 0.0003
271 CERVICAL VERTEBRAL FRACTURE 1 0.0003
272 MACULOPATHY 1 0.0003
273 PRODUCT CONTAMINATION 1 0.0003
274 RENAL TRANSPLANT 1 0.0003
275 SCLERODERMA 1 0.0003
276 CUTANEOUS VASCULITIS 1 0.0003
277 PRODUCT STORAGE ISSUE 1 0.0003
278 LOSS OF CONTROL OF LEGS 1 0.0003
279 GINGIVAL DISORDER 1 0.0003
280 REHABILITATION THERAPY 1 0.0003
281 PULMONARY HAEMORRHAGE 2 0.0003
282 MULTIPLE ALLERGIES 2 0.0003
283 NAIL DISCOLOURATION 1 0.0003
284 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
285 FUNGAL SKIN INFECTION 1 0.0002
286 PRODUCT ADMINISTRATION ERROR 5 0.0002
287 PHOTOSENSITIVITY REACTION 4 0.0002
288 APPLICATION SITE IRRITATION 3 0.0002
289 INTERVERTEBRAL DISC DISORDER 1 0.0002
290 VISUAL IMPAIRMENT 29 0.0002
291 SCAR 4 0.0002
292 INFUSION SITE PAIN 3 0.0002
293 MELANOCYTIC NAEVUS 1 0.0002
294 APPLICATION SITE PAIN 5 0.0002
295 EAR DISORDER 1 0.0002
296 EYE DISORDER 7 0.0002
297 BLINDNESS UNILATERAL 3 0.0002
298 RENAL FAILURE 28 0.0002
299 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
300 PRODUCT PRESCRIBING ERROR 5 0.0002
301 RECALLED PRODUCT ADMINISTERED 2 0.0002
302 PHARYNGEAL SWELLING 2 0.0002
303 RENAL INJURY 6 0.0002
304 MUCOUS STOOLS 1 0.0002
305 ANEURYSM 1 0.0002
306 VEIN DISORDER 1 0.0002
307 VULVOVAGINAL PRURITUS 1 0.0002
308 EYELID PTOSIS 2 0.0002
309 AMMONIA INCREASED 1 0.0002
310 PHLEBITIS 1 0.0002
311 PRODUCT COLOUR ISSUE 1 0.0002
312 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
313 WEIGHT FLUCTUATION 2 0.0002
314 ANAL FISSURE 1 0.0002
315 PRODUCT RESIDUE PRESENT 1 0.0002
316 FAECES DISCOLOURED 4 0.0002
317 ASTHENOPIA 1 0.0002
318 PRODUCT LEAKAGE 1 0.0002
319 IMPAIRED DRIVING ABILITY 2 0.0002
320 SKIN ATROPHY 1 0.0002
321 BLINDNESS 7 0.0002
322 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
323 MACULAR DEGENERATION 2 0.0002
324 HYPERLIPIDAEMIA 2 0.0002
325 SYMPTOM RECURRENCE 1 0.0002
326 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
327 PIGMENTATION DISORDER 1 0.0002
328 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
329 CONJUNCTIVITIS 3 0.0002
330 PRE-EXISTING CONDITION IMPROVED 1 0.0002
331 INFUSION SITE SWELLING 1 0.0002
332 GLAUCOMA 3 0.0002
333 HAEMOGLOBIN ABNORMAL 1 0.0002
334 CARDIAC FLUTTER 1 0.0002
335 APPLICATION SITE VESICLES 1 0.0002
336 TENDON DISORDER 1 0.0002
337 POLYP 1 0.0002
338 APPLICATION SITE ERYTHEMA 4 0.0002
339 SOMNAMBULISM 1 0.0002
340 DYSGRAPHIA 1 0.0002
341 WALKING AID USER 1 0.0002
342 PRODUCT FORMULATION ISSUE 1 0.0002
343 EXPIRED PRODUCT ADMINISTERED 5 0.0002
344 TERMINAL STATE 1 0.0001
345 QUALITY OF LIFE DECREASED 2 0.0001
346 COLITIS ISCHAEMIC 1 0.0001
347 WRONG PRODUCT ADMINISTERED 1 0.0001
348 PRODUCT LABEL ISSUE 1 0.0001
349 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
350 ONYCHOCLASIS 1 0.0001
351 HAIR GROWTH ABNORMAL 1 0.0001
352 DERMATITIS 3 0.0001
353 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
354 THERMAL BURN 1 0.0001
355 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 10 0.0001
356 VISUAL FIELD DEFECT 1 0.0001
357 PRODUCT PRESCRIBING ISSUE 3 0.0001
358 INTENTIONAL UNDERDOSE 1 0.0001
359 BLINDNESS TRANSIENT 1 0.0001
360 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
361 TOOTH DISORDER 3 0.0001
362 DUODENAL ULCER PERFORATION 1 0.0001
363 SUNBURN 1 0.0001
364 PAROSMIA 1 0.0001
365 BOWEL MOVEMENT IRREGULARITY 1 0.0001
366 ANKLE FRACTURE 2 0.0001
367 CONCUSSION 1 0.0001
368 BASAL CELL CARCINOMA 2 0.0001
369 FURUNCLE 1 0.0001
370 NASAL DISCOMFORT 1 0.0001
371 RENAL CYST 1 0.0001
372 GINGIVAL PAIN 1 0.0001
373 ATRIAL FLUTTER 1 0.0001
374 PRODUCT QUALITY ISSUE 17 0.0001
375 BLISTER 7 0.0001
376 ACUTE KIDNEY INJURY 19 0.0001
377 RHINITIS 1 0.0001
378 ABNORMAL FAECES 1 0.0001
379 HERPES ZOSTER 7 0.0001
380 HYPERAESTHESIA 1 0.0001
381 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
382 VENTRICULAR TACHYCARDIA 2 0.0001
383 SPINAL COMPRESSION FRACTURE 1 0.0001
384 PSEUDOMONAS INFECTION 1 0.0001
385 SKIN HYPERPIGMENTATION 1 0.0001
386 NEUROPATHY PERIPHERAL 11 0.0001
387 DIPLOPIA 3 0.0001
388 DISCOMFORT 7 0.0001
389 ANHEDONIA 3 0.0001
390 BLOOD CALCIUM INCREASED 1 0.0001
391 GROIN PAIN 1 0.0001
392 LUNG INFILTRATION 1 0.0001
393 FACIAL PAIN 1 0.0001
394 ANAL INCONTINENCE 1 0.0001
395 TREATMENT NONCOMPLIANCE 6 0.0001
396 PNEUMONIA BACTERIAL 1 0.0001
397 INCREASED TENDENCY TO BRUISE 1 0.0001
398 MENTAL STATUS CHANGES 3 0.0001
399 PRODUCT DISTRIBUTION ISSUE 1 0.0001
400 PRODUCT DOSE OMISSION 7 0.0001
401 HEPATIC ENCEPHALOPATHY 1 0.0001
402 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
403 LACERATION 1 0.0001
404 SQUAMOUS CELL CARCINOMA 1 0.0001
405 SPINAL DISORDER 1 0.0001
406 FEELING JITTERY 2 0.0001
407 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
408 POST PROCEDURAL COMPLICATION 2 0.0001
409 RENAL TUBULAR NECROSIS 1 0.0001
410 KNEE OPERATION 1 0.0001
411 SINUS DISORDER 2 0.0001
412 BLOOD PRESSURE ABNORMAL 2 0.0001
413 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
414 PRODUCT PHYSICAL ISSUE 2 0.0001
415 EXTRA DOSE ADMINISTERED 4 0.0001
416 DRY THROAT 1 0.0001
417 MOTOR DYSFUNCTION 1 0.0001
418 THERAPY INTERRUPTED 7 0.0001
419 LUNG NEOPLASM MALIGNANT 4 0.0001
420 INFLAMMATION 5 0.0001
421 KNEE ARTHROPLASTY 2 0.0001
422 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
423 INCONTINENCE 1 0.0001
424 RENAL PAIN 1 0.0001
425 BODY HEIGHT DECREASED 1 0.0001
426 HEREDITARY ANGIOEDEMA 1 0.0001
427 RHINORRHOEA 6 0.0001
428 CONDITION AGGRAVATED 28 0.0001
429 SKIN LACERATION 1 0.0001
430 WOUND INFECTION 1 0.0001
431 STAPHYLOCOCCAL INFECTION 3 0.0001
432 TOOTH FRACTURE 1 0.0001
433 NERVE INJURY 1 0.0001
434 MALNUTRITION 1 0.0001
435 GLOSSODYNIA 2 0.0001
436 SNEEZING 2 0.0001
437 TYPE 2 DIABETES MELLITUS 3 0.0001
438 OFF LABEL USE 78 0.0001
439 PRODUCT USE IN UNAPPROVED INDICATION 22 0.0001
440 CHROMATURIA 2 0.0001
441 REBOUND EFFECT 1 0.0001
442 SCAB 1 0.0001
443 MICTURITION URGENCY 1 0.0001
444 PERICARDIAL EFFUSION 2 0.0001
445 VASCULITIS 1 0.0001
446 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
447 ACCIDENTAL OVERDOSE 3 0.0001
448 SPINAL OPERATION 1 0.0001
449 TENDON RUPTURE 1 0.0001
450 TOOTH EXTRACTION 1 0.0001
451 SECRETION DISCHARGE 1 0.0001
452 MUSCLE ATROPHY 1 0.0001
453 SWELLING FACE 5 0.0001
454 PULMONARY CONGESTION 1 0.0001
455 SARS-COV-2 TEST POSITIVE 1 0.0001
456 DISORIENTATION 3 0.0001
457 HAIR TEXTURE ABNORMAL 1 0.0001
458 SINUS CONGESTION 1 0.0001
459 THROAT TIGHTNESS 2 0.0001
460 PRODUCT TASTE ABNORMAL 1 0.0001
461 RESPIRATORY DISTRESS 2 0.0001
462 NECK PAIN 4 0.0001
463 CARPAL TUNNEL SYNDROME 1 0.0001
464 BURNING SENSATION 5 0.0001
465 SEASONAL ALLERGY 1 0.0001
466 BRONCHOSPASM 1 0.0001
467 DEVICE DISLOCATION 3 0.0001
468 INTENTIONAL PRODUCT MISUSE 6 0.0001
469 DYSSTASIA 2 0.0001
470 BRONCHITIS 5 0.0001
471 SKIN HAEMORRHAGE 1 0.0001
472 DYSGEUSIA 5 0.0001
473 HAEMORRHAGE INTRACRANIAL 1 0.0001
474 HYPOAESTHESIA ORAL 1 0.0001
475 NO ADVERSE EVENT 12 0.0001
476 UNEVALUABLE EVENT 5 0.0001
477 ECONOMIC PROBLEM 1 0.0001
478 THERAPEUTIC RESPONSE DECREASED 4 0.0001
479 OSTEOPENIA 1 0.0001
480 TOXICITY TO VARIOUS AGENTS 11 0.0001
481 DRUG ADMINISTRATION ERROR 2 0.0001
482 PHARYNGEAL OEDEMA 1 0.0001
483 DEVICE RELATED INFECTION 1 0.0001
484 THYROID DISORDER 1 0.0001
485 TENDONITIS 1 0.0001
486 THERAPY PARTIAL RESPONDER 1 0.0001
487 SWOLLEN TONGUE 2 0.0001
488 BONE DENSITY DECREASED 2 0.0001
489 BRAIN FOG 1 0.0001
490 PRODUCT USE COMPLAINT 1 0.0001
491 HEAD INJURY 2 0.0001
492 CYSTITIS 2 0.0001
493 BLOOD POTASSIUM INCREASED 1 0.0001
494 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001
495 MULTIPLE FRACTURES 1 0.0001
496 VIRAL INFECTION 2 0.0001
497 LIP SWELLING 2 0.0001
498 FUNGAL INFECTION 2 0.0001
499 PERICARDITIS 1 0.0001
500 CANDIDA INFECTION 1 0.0001
501 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
502 BLOOD PRESSURE INCREASED 9 0.0001
503 SINUSITIS 6 0.0001
504 THERAPY CESSATION 3 0.0001
505 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
506 DEVICE USE ISSUE 1 0.0001
507 METASTASES TO LIVER 1 0.0001
508 COLD SWEAT 1 0.0001
509 SLEEP DISORDER 4 0.0001
510 LYMPHOCYTE COUNT DECREASED 1 0.0001
511 HEAD DISCOMFORT 1 0.0001
512 GOUT 1 0.0001
513 OEDEMA 3 0.0001
514 TOOTHACHE 1 0.0001
515 OSTEOMYELITIS 1 0.0001
516 CRYING 2 0.0001
517 BONE DISORDER 1 0.0001
518 BLOOD GLUCOSE ABNORMAL 1 0.0001
519 URTICARIA 9 0.0001
520 EPISTAXIS 4 0.0001
521 FRACTURE 1 0.0001
522 FOOT FRACTURE 1 0.0001
523 DYSPHAGIA 5 0.0001
524 BLOOD URINE PRESENT 1 0.0001
525 GASTRIC ULCER 1 0.0001
526 PROTEINURIA 1 0.0001
527 DIABETES MELLITUS 4 0.0001
528 SLEEP APNOEA SYNDROME 1 0.0001
529 INJECTION SITE SWELLING 4 0.0001
530 ERUCTATION 1 0.0001
531 EAR PAIN 1 0.0001
532 PLASMA CELL MYELOMA 2 0.0001
533 NASAL CONGESTION 3 0.0001
534 PRESCRIBED UNDERDOSE 1 0.0001
535 FULL BLOOD COUNT DECREASED 1 0.0000
536 FEEDING DISORDER 1 0.0000
537 INJURY ASSOCIATED WITH DEVICE 1 0.0000
538 BODY TEMPERATURE INCREASED 1 0.0000
539 RIB FRACTURE 1 0.0000
540 PERITONITIS 1 0.0000
541 TOOTH LOSS 1 0.0000
542 HALLUCINATION, VISUAL 1 0.0000
543 OSTEOARTHRITIS 2 0.0000
544 JOINT INJURY 1 0.0000
545 IMPAIRED WORK ABILITY 1 0.0000
546 RECTAL HAEMORRHAGE 2 0.0000
547 SKIN CANCER 1 0.0000
548 PRURITUS GENERALISED 1 0.0000
549 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
550 PRODUCT DISPENSING ERROR 1 0.0000
551 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
552 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
553 RASH PAPULAR 1 0.0000
554 ADVERSE DRUG REACTION 4 0.0000
555 DIZZINESS 22 0.0000
556 MUSCULAR WEAKNESS 5 0.0000
557 MEMORY IMPAIRMENT 6 0.0000
558 MUSCLE SPASMS 8 0.0000
559 TINNITUS 2 0.0000
560 SKIN DISCOLOURATION 2 0.0000
561 OROPHARYNGEAL PAIN 4 0.0000
562 SWELLING 4 0.0000
563 DRUG DOSE OMISSION 7 0.0000
564 FALL 14 0.0000
565 RASH ERYTHEMATOUS 2 0.0000
566 MULTIPLE SCLEROSIS 2 0.0000
567 BLOOD PRESSURE FLUCTUATION 1 0.0000
568 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
569 LOCALISED INFECTION 1 0.0000
570 EMOTIONAL DISTRESS 5 0.0000
571 FIBROMYALGIA 1 0.0000
572 CEREBRAL INFARCTION 1 0.0000
573 DYSPEPSIA 4 0.0000
574 ABASIA 1 0.0000
575 DIARRHOEA 26 0.0000
576 PNEUMONIA 13 0.0000
577 AGEUSIA 1 0.0000
578 HYPOAESTHESIA 6 0.0000
579 SYNCOPE 4 0.0000
580 CELLULITIS 2 0.0000
581 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
582 HYPOPHAGIA 1 0.0000
583 PRURITUS 15 0.0000
584 PERIPHERAL SWELLING 6 0.0000
585 SKIN ULCER 1 0.0000
586 ANXIETY 11 0.0000
587 HAEMATOMA 1 0.0000
588 HEADACHE 24 0.0000
589 PRODUCT DOSE OMISSION ISSUE 11 0.0000
590 FEAR 1 0.0000
591 FREQUENT BOWEL MOVEMENTS 1 0.0000
592 LIMB INJURY 1 0.0000
593 ANAPHYLACTIC REACTION 2 0.0000
594 DIVERTICULITIS 1 0.0000
595 PROCEDURAL PAIN 1 0.0000
596 WOUND 1 0.0000
597 FLATULENCE 2 0.0000
598 URINARY TRACT INFECTION 6 0.0000
599 INTENTIONAL DOSE OMISSION 1 0.0000
600 HYPERSOMNIA 1 0.0000
601 LETHARGY 2 0.0000
602 FATIGUE 27 0.0000
603 ASTHENIA 13 0.0000
604 NEEDLE ISSUE 1 0.0000
605 PRODUCT STORAGE ERROR 3 0.0000
606 PALPITATIONS 4 0.0000
607 BONE PAIN 2 0.0000
608 SURGERY 2 0.0000
609 DISEASE PROGRESSION 4 0.0000
610 GASTROINTESTINAL DISORDER 3 0.0000
611 DEVICE ISSUE 3 0.0000
612 BLOOD POTASSIUM DECREASED 1 0.0000
613 HYPERTENSION 7 0.0000
614 STOMATITIS 2 0.0000
615 PAIN 20 0.0000
616 CONSTIPATION 7 0.0000
617 GAIT DISTURBANCE 6 0.0000
618 HYPOTHYROIDISM 1 0.0000
619 HIP FRACTURE 1 0.0000
620 ATRIAL FIBRILLATION 3 0.0000
621 DEEP VEIN THROMBOSIS 2 0.0000
622 DEPRESSION 7 0.0000
623 INCORRECT DOSE ADMINISTERED 7 0.0000
624 NAUSEA 24 0.0000
625 HEART RATE INCREASED 3 0.0000
626 URINARY RETENTION 1 0.0000
627 DRY SKIN 4 0.0000
628 GAIT INABILITY 1 0.0000
629 FLUSHING 3 0.0000
630 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
631 ERYTHEMA 6 0.0000
632 ABDOMINAL PAIN UPPER 6 0.0000
633 GASTRIC DISORDER 1 0.0000
634 ILLNESS 3 0.0000
635 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
636 NIGHTMARE 1 0.0000
637 NEOPLASM PROGRESSION 1 0.0000
638 ABDOMINAL DISTENSION 3 0.0000
639 MYOCARDIAL INFARCTION 5 0.0000
640 COUGH 8 0.0000
641 HYPERKALAEMIA 1 0.0000
642 COVID-19 5 0.0000
643 HEART RATE DECREASED 1 0.0000
644 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
645 CEREBRAL HAEMORRHAGE 1 0.0000
646 DRUG INEFFECTIVE 36 0.0000
647 DYSURIA 1 0.0000
648 NASOPHARYNGITIS 5 0.0000
649 INFLUENZA 3 0.0000
650 HEPATIC FUNCTION ABNORMAL 1 0.0000
651 HALLUCINATION 2 0.0000
652 HOT FLUSH 2 0.0000
653 COLITIS 1 0.0000
654 HOSPITALISATION 4 0.0000
655 SEIZURE 3 0.0000
656 ALOPECIA 5 0.0000
657 ARTHRITIS 2 0.0000
658 RASH 11 0.0000
659 ABORTION SPONTANEOUS 1 0.0000
660 THROMBOSIS 2 0.0000
661 CONFUSIONAL STATE 4 0.0000
662 DYSKINESIA 1 0.0000
663 OSTEOPOROSIS 1 0.0000
664 INJECTION SITE ERYTHEMA 3 0.0000
665 POLLAKIURIA 1 0.0000
666 ROAD TRAFFIC ACCIDENT 1 0.0000
667 ABDOMINAL DISCOMFORT 4 0.0000
668 PAIN IN EXTREMITY 7 0.0000
669 LOSS OF CONSCIOUSNESS 3 0.0000
670 MUSCULOSKELETAL STIFFNESS 2 0.0000
671 LIVER DISORDER 1 0.0000
672 INSOMNIA 6 0.0000
673 DEHYDRATION 3 0.0000
674 COLITIS ULCERATIVE 1 0.0000
675 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
676 THROAT IRRITATION 1 0.0000
677 THERAPY NON-RESPONDER 1 0.0000
678 NEPHROLITHIASIS 1 0.0000
679 ADVERSE EVENT 2 0.0000
680 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
681 CHEST PAIN 4 0.0000
682 WEIGHT DECREASED 6 0.0000
683 PRODUCT USE ISSUE 4 0.0000
684 DYSPNOEA 12 0.0000
685 ARRHYTHMIA 1 0.0000
686 DISEASE RECURRENCE 1 0.0000
687 MIGRAINE 2 0.0000
688 FEELING ABNORMAL 5 0.0000
689 INFECTION 3 0.0000
690 HYPOGLYCAEMIA 1 0.0000
691 MALAISE 9 0.0000
692 SOMNOLENCE 4 0.0000
693 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
694 FLUID RETENTION 1 0.0000
695 HAEMOGLOBIN DECREASED 2 0.0000
696 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
697 NERVOUSNESS 1 0.0000
698 SPEECH DISORDER 1 0.0000
699 PARAESTHESIA 3 0.0000
700 PANCREATITIS 1 0.0000
701 PLATELET COUNT DECREASED 2 0.0000
702 DISTURBANCE IN ATTENTION 1 0.0000
703 RASH PRURITIC 1 0.0000
704 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
705 SEPSIS 2 0.0000
706 CONVULSION 1 0.0000
707 DECREASED APPETITE 4 0.0000
708 CHILLS 2 0.0000
709 JOINT SWELLING 2 0.0000
710 PLEURAL EFFUSION 1 0.0000
711 OEDEMA PERIPHERAL 2 0.0000
712 FEELING HOT 1 0.0000
713 BLOOD CREATININE INCREASED 1 0.0000
714 DEVICE DIFFICULT TO USE 1 0.0000
715 DEATH 13 0.0000
716 INFUSION RELATED REACTION 1 0.0000
717 BLOOD PRESSURE DECREASED 1 0.0000
718 VOMITING 7 0.0000
719 HEPATIC ENZYME INCREASED 1 0.0000
720 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
721 INJECTION SITE REACTION 1 0.0000
722 PYREXIA 5 0.0000
723 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
724 SKIN BURNING SENSATION 1 0.0000
725 MOBILITY DECREASED 1 0.0000
726 RESPIRATORY FAILURE 1 0.0000
727 BACK PAIN 3 0.0000
728 DRUG INTERACTION 2 0.0000
729 INJECTION SITE BRUISING 1 0.0000
730 CARDIAC FAILURE 1 0.0000
731 CARDIAC FAILURE CONGESTIVE 1 0.0000
732 DRY MOUTH 1 0.0000
733 INFLUENZA LIKE ILLNESS 1 0.0000
734 TREMOR 2 0.0000
735 RENAL IMPAIRMENT 1 0.0000
736 CEREBROVASCULAR ACCIDENT 2 0.0000
737 BALANCE DISORDER 1 0.0000
738 BREAST CANCER 1 0.0000
739 BLOOD GLUCOSE INCREASED 2 0.0000
740 ANAEMIA 2 0.0000
741 CONTUSION 1 0.0000
742 INJECTION SITE PAIN 3 0.0000
743 OVERDOSE 2 0.0000
744 WEIGHT INCREASED 2 0.0000
745 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
746 ABDOMINAL PAIN 2 0.0000
747 HYPERHIDROSIS 1 0.0000
748 PSORIASIS 1 0.0000
749 NEUTROPENIA 1 0.0000
750 MYALGIA 1 0.0000
751 HYPOTENSION 1 0.0000